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Abstract
Viruses rely on the host translation machinery for the synthesis of viral proteins. Human cells have 
evolved sensors that recognize viral RNAs and inhibit mRNA translation in order to limit virus 
replication. Understanding how viruses manipulate the host translation machinery to gain access to 
ribosomes and disable the antiviral response is therefore a critical aspect of the host:pathogen 
interface. In this study we used a proteomics approach to identify human cytomegalovirus 
(HCMV) proteins that might contribute to viral mRNA translation. The HCMV TRS1 protein 
(pTRS1) associated with the 7-methylguanosine (m7G) mRNA cap, increased the total level of 
protein synthesis, and co-localized with mRNAs undergoing translation initiation during infection. 
pTRS1 stimulated translation of a non-viral reporter gene and increased the translation of a 
reporter containing an HCMV 5’ untranslated region (5’UTR) to a greater extent. The preferential 
effect of pTRS1 on translation of an mRNA containing a viral 5’UTR required the pTRS1 RNA 
and PKR binding domains, and was likely the result of PKR inhibition. However pTRS1 also 
stimulated the total level of protein synthesis and translation directed by an HCMV 5’UTR in cells 
lacking PKR. Thus our results demonstrate that pTRS1 stimulates translation through both PKR-
dependent and PKR-independent mechanisms.
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1 Introduction
The regulation of mRNA translation is a critical interface between viruses and the infected 
host cell. Viral mRNAs are completely reliant on host machinery for the synthesis of viral 
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proteins, as viruses require host ribosomes to translate their mRNAs. The infected cell 
senses the presence of viral RNAs and activates signaling pathways that attempt to suppress 
viral protein expression. At the same time the cell must translate antiviral proteins to limit 
virus replication. The interface of viral mRNAs with the host translation machinery is 
therefore a fundamental aspect of the host: pathogen relationship.
Most eukaryotic mRNAs initiate translation through the ordered assembly of translation 
initiation factors on their 5’ terminus [1, 2]. The eIF4F complex binds to the 7-
methylguanosine (m7G) mRNA cap and recruits 40S ribosomal subunits to the 5’ end of the 
transcript [3]. Bound 40S subunits then scan the 5’ untranslated region (5’UTR) of the 
mRNA until reaching the translation initiation codon, where the eIF2 complex pairs a 
charged methionine tRNA to the AUG initiation codon triggering ribosome assembly and 
translation elongation. Multiple regulatory cues govern the initiation phase, which is the 
rate-limiting step in protein synthesis. The mTOR kinase promotes translation initiation by 
antagonizing the translation repressor 4EBP1, which blocks assembly of the host eIF4F 
translation initiation complex [4]. The phosphorylation of the eIF2α subunit of the eIF2 
complex is an additional regulatory step in translation initiation. Cell stressors including ER 
stress, nutrient deprivation or viral infection activate kinases that phosphorylate and 
inactivate eIF2α, which inhibits its ability to recycle GDP to GTP and thus blocks its ability 
to participate in further rounds of translation initiation [5]. Together these regulatory steps 
ensure tight control of mRNA translation that is matched to the physiological state of the 
cell.
Viral infection induces cell stress responses that would limit mRNA translation if left 
unchecked. Not surprisingly, viruses have evolved mechanisms to counteract these stress 
responses to ensure efficient viral mRNA translation. Human cytomegalovirus (HCMV) 
encodes proteins that ensure eIF4F and eIF2α remain active throughout infection. HCMV 
pUL38 antagonizes the tuberous sclerosis complex (TSC), preventing it from suppressing 
mTOR activity and limiting eIF4F abundance [6]. HCMV pTRS1 prevents activation of the 
antiviral eIF2α kinase PKR during infection with a heterologous virus [7-10]. As a result, 
host translation initiation factor activity and host protein synthesis are maintained during 
HCMV infection.
It is also likely that HCMV encodes additional proteins that regulate translation initiation. 
While HCMV stimulates the accumulation of the eIF4F complex in infected cells [11, 12], 
the role of eIF4F in viral protein synthesis is unclear. mTOR activity is required for ongoing 
host protein synthesis during HCMV infection. However during the late stage of infection, 
HCMV protein synthesis and viral replication are minimally affected by disruption or 
inhibition of the eIF4F complex [13, 14]. HCMV protein synthesis similarly becomes 
resistant to inhibition by stressors that inactivate eIF2α late in infection [15, 16]. Infection 
strongly activates the eIF2α kinase PERK, yet eIF2α is minimally phosphorylated and 
translation is maintained. These results suggest that, at least late in infection, viral mRNAs 
can preferentially recruit residual active eIF4F or eIF2α, or that an alternative set of host or 
viral factors acts to promote viral protein synthesis.
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In this study we focused on identifying HCMV proteins that regulate mRNA translation. 
Using a proteomics based approach we found that the HCMV pTRS1 and pIRS1 proteins 
associate with the mRNA cap in infected cells. pTRS1 association with the mRNA cap did 
not require additional viral proteins or the host eIF4F translation initiation complex. We find 
that pTRS1 associated with actively initiating mRNAs during infection, and increased the 
translation of reporter genes outside of infection. While pTRS1 generally enhanced 
translation, it preferentially stimulated the translation of mRNAs containing specific 
sequences or features. Our results suggest that the preferential stimulation of translation was 
dependent on the ability of pTRS1 to inhibit PKR. However, pTRS1 was sufficient to 
increase translation in cells lacking PKR, and thus pTRS1 also enhances translation in a 
PKR-independent manner. Our data suggests that pTRS1 expression may provide a 
mechanism to ensure that viral transcripts are efficiently translated under conditions that 
limit the activity of the host translation machinery while also limiting the host antiviral 
response.
2 Materials and Methods
2.1 Cells, Viruses and Plasmids
Primary human foreskin fibroblasts (HFFs), passages 5-14, were cultured in DMEM 
containing 10% newborn calf serum. HeLa cells were cultured in DMEM containing 10% 
fetal bovine serum. The BAC-derived BADinGFP strain of HCMV was used as the wild-
type virus in these studies [17]. The BADinTRS1GFP and BADinIRS1GFP variants were 
made using lambda/red-mediated recombineering using the BADwt BAC as the parental 
strain using methods described previously [6]. The mutants express either pTRS1 or pIRS1, 
respectively, with a C-terminal GFP fusion from their endogenous locations in the HCMV 
genome under the control of their native promoters, and both replicate with the same 
kinetics as its parental strain. Viruses were propagated and titered by the TCID50 method in 
HFFs.
pTRS1 expression plasmids were generously provided by A. Geballe (Univ. of 
Washington), and have been previously described [8, 9]. The full length or truncated UL99 
5’UTR (nucleotides 144,872 to 145,348 or 145,115 to 145,348, respectively) was amplified 
by PCR from the HCMV AD169 genome (GenBank FJ527563.1) using primers containing 
HindIII or NotI sites flanking the viral sequence (UL99FL-F 5’ 
GATCATCAAGCTTGACGCCGCTGGCGGCGGCGCTGATC 3’. UL99trunc-F 5’ 
GATCATCAAGCTTATTTCCGCGACCTGCCTACCGTC 3’, UL99FL-R 5’ 
GATGATCCCATGGATCGGTAGGTTCGTCTTGCG 3’). The resulting PCR products 
were cloned into the HindIII and NotI sites of the pGL3 Control vector (Promega), and 
sequence verified. The UL44 5’UTR was PCR amplified and cloned using the following 
primers: UL44F 5’ GATCATCAAGCTTGGCTCGGCGCGGCTGTATTATTAG 3’, 
UL44R 5’ GATGATCCCATGGCCCGGACAGCGTGCAAGTCTC 3’. The IE1 5’UTR 
was amplified from infected cell cDNA using the following primers: IE1F 5’ 
GGAGGCCTAGGCTTTTGCAAAACAGATCGCCTGGAGACGCCATC 3’, IE1R 5’ 
TTATGTTTTTGGCGTCTTCCATCGTGTCAAGGACGGTGAGTCAC 3’.The PCR 
products was cloned by Gibson assembly into the Hind III and NotI sites of the pGL3-
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Control vector. The GAPDH 5’ UTR (accession# NM_002046.4) was synthesized (IDT) 
and cloned into the HindIII and NcoI sites of the pGL3-Control vector using Gibson 
assembly. Two oligonucleotides each containing half of the actin UTR (accession # 
NM_001101.3) were annealed and extended with Klenow to generate double stranded DNA, 
and then cloned into the HindIII and NcoI sites of pGL3-Control by Gibson cloning. The 
tubulin 5’UTR (accession # NM_178014.2) construct was generated in the same manner. 
All constructs were sequenced verified.
2.2 Analysis of m7G-Sepharose-Bound Proteins
HFFs were infected with BADinGFP virus at a multiplicity of 3 IU/cell. The affinity 
purification of proteins associated with the m7G sepharose was performed similarly to that 
described in ref [18] with the following modifications. Cell lysates were prepared at 72 
hours after infection and incubated with m7G-sepharose for 1 hour in cap binding buffer 
(40mM HEPES, pH 7.6; 120mM NaCl; 1mM EDTA; 0.3% CHAPS). The beads were 
washed at room temperature three times in cap binding buffer, once in cap binding buffer 
containing 500 mM KCl and then incubated in elution buffer (100 mM m7GTP, 100 mM 
KCl, 1 mM DTT, 50 mM HEPES, pH 7.6) for 1 hour to release proteins from the beads. 
Eluted proteins were reduced with DTT (10mM) and alkylated with iodoacetamide. The 
samples were then digested with trypsin (Promega), and desalted and purified on Zip-Tip 
C18 columns (Millipore). The peptides were then separated by reverse phase nanospray 
liquid chromatography on C18 resin with an Agilent 1200 series HPLC. Mass spectrometry 
was performed on a LTQ-Orbitrap mass spectrometer (ThermoFisher Scientific). Protein 
identification was performed using Protein Discoverer software version 1.4 with the 
MASCOT or SEQUEST search algorithms against the most current version of the Uniprot 
Human database. A custom HCMV reference proteome was derived from the HCMV 
AD169 genome (Genbank # FJ527563). We allowed for 2 missed cleavages. Precursor mass 
tolerance was set to 10 ppm, and fragment mass tolerance to 0.6 Da. Dynamic modifications 
included oxidized methionine and carbamidomethylated cysteine. Target FDR was set to 
0.05. To confirm the specificity we performed our capture with sepharose only (no m7GTP) 
beads and identified co-purifying proteins by mass spectrometry as above. Proteins 
recovered from sepharose only beads that were also purified with m7G-sepharose (Fig. S5) 
were considered likely contaminants, and are denoted as such in Table S1.
A similar approach was used to measure the association of specific host and viral proteins 
with the m7G mRNA cap. Transfected or infected cells lysates or partially purified pTRS1 
was incubated with m7G agarose (Jena Bioscience #AC-155S) as above, and the bound 
proteins were analyzed by Western blot.
2.3 Partial Purification of pTRS1
293T cells were transfected with his epitope-tagged pTRS1 expression vector and harvested 
48 hours after transfection. Cells were lysed in cap binding buffer (above) containing 5 mM 
imidazole and treated with micrococcal nuclease. pTRS1 was captured from the lysates 
using His-Select Affinity Gel (Sigma #114K70151) and eluted with 250mM imidazole in 
cap binding buffer. Protein concentration was determined using a BCA assay (Pierce). 
pTRS1 (5 pmol) in cap binding buffer was used in the m7GTP agarose-binding assay.
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HeLa cells in 12 well dishes were transfected with 0.5 μg of the luciferase reporter together 
with the indicated concentrations of the TRS1 expression plasmid. Luciferase activity was 
measured in a luminometer (Molecular Devices) at 24 hours after transfection. Luciferase 
activity was normalized to the protein content of the lysate as determined by Bradford assay. 
In each case the results are compiled from at least three independent experiments.
2.5 RNA Quantification
Total RNA was extracted using Trizol reagent. DNase-treated RNA was reverse transcribed 
as described previously [19]. Quantitative real-time PCR (qRT-PCR) was performed to 
assess changes in luciferase mRNA abundance using the following primers: luciferase 5’-
ACAAAGGCTATCAGGTGGCT-3’, 5’-CGTGCTCCAAAACAACAACG-3’; GAPDH 5’-
CTGTTGCTGTAGCCAAATTCGT-3’, 5’-ACCCACTCCTCCACCTTTGAC-3’. The 
abundance of luciferase RNA was determined by the ΔΔCt method using GAPDH as the 
reference transcript as previously described [20].
2.6 Protein Analyses
For metabolic labeling of nascent proteins, cells were incubated with 125 μCi 35S-labeled 
amino acids (EasyTag Express; GE Health Sciences) for 30 minutes in methionine- and 
cysteine-free media at 24 h post transfection. The amount of radioactivity incorporated into 
TCA-insoluble protein was quantified using a scintillation counter and normalized to the 
protein concentration in the sample as determined by the Bradford assay (Sigma-Aldrich).
For immunofluorescence analysis, HFFs were infected with the indicated virus at a 
multiplicity of 0.5 IU/cell, and 72 hours later cells were fixed and stained as described 
previously [6]. In some cases cells were treated with thapsigargin (1 μM) or sodium arsenite 
(0.5 mM) for 1 hour prior to fixation to induce the formation of stress granules [21]. Images 
were captured on a Zeiss confocal microscope. Antibodies specific for G3BP1 (BD 
Biosciences), eIF4E, eF4G, or eIF4A (Cell Signaling; 1:100 dilution) and DAPI were used 
to visualize stress granules, translation initiation factors and nuclei, respectively.
For Western blot assays, equal amounts of protein were analyzed as described previously 
[22] using antibodies specific to the following antigens: his epitope tag, eIF4E, eIF4G, 
4EBP1, and PABP1 (Cell Signaling) at 1:1000 dilution; PKR (Santa Cruz), PKR phospho-
T446 (Epitomics), and GFP (Roche) at 1:1000 dilution; pTRS1 [23] at 1:100 dilution.
2.7 Velocity Sedimentation Analysis of Ribosomal Subunits
Cytoplasmic extracts from pTRS1-GFP infected cells (multiplicity of 3 IU/cell; 72 hpi) were 
treated with puromycin for 1 hour prior to harvest. The cells were lysed in polysome lysis 
buffer [14] and the extracts resolved on 5-20% linear sucrose gradients. The proteins in a 
portion of each fraction were precipitated with TCA and analyzed by Western blot. The 
gradient was manually fractionated from the top, and total RNA was extracted from a 
portion of each fraction. RNA from each fraction was resolved by electrophoresis on non-
denaturing 2% agarose gels to visualize the distribution of ribosomal RNA.
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2.8 Depletion or Disruption of PKR
HeLa cells were transduced with lentivirus expressing PKR shRNAs (TRCN0000001380 
and TRCN0000001382, PKR #1 and #2 respectively). Lentivirus stocks were generated by 
co-transfecting 293T cells with the TRCN expression vector (obtained from the UNC 
Lentivirus Core Facility) and packaging plasmids as previously described [14]. HeLa cells 
were transduced in the presence of polybrene (5μg/ml). shRNA expressing cells were 
selected with puromycin (1μg/mL) and PKR knockdown was evaluated by western blot 
analysis.
pLX-sgRNA and pCW-Cas9 [24] vectors were obtained from Addgene. HeLa cells were 
transduced with pCW-Cas9 lentivirus and then clonally selected in the presence of 
puromycin (1μg/mL) to create a stable HeLa line expressing Cas9 under the inducible 
control of the Tet ON promoter (HeLa-Cas9). Oligonucleotides containing PKR-specific 
guide RNAs were (ref[24], 5’ TTCAGCAGGTTTCTTCATGGAGG 3’; PAM motif 
underlined) cloned into pLX-sgRNA in the place of the AAVS1 target sequence to create 
pLX-sgPKR. pLX-sgPKR was transfected into HeLa-Cas9 and the cells were grown and 
passaged in the presence of doxycycline (1μg/ml) and blasticidin (1μg/ml). The Surveyor 
Assay (Transgenomic #706025) was used to confirm the introduction of mutations into the 
PKR gene. The cells were clonally selected by limiting dilution, and loss of PKR expression 
in individual clones was determined by Western blot.
3 Results
3.1 HCMV pTRS1 binds to the 5’ mRNA cap
To identify viral factors that might regulate protein synthesis, we used a mass spectrometry 
based approach to identify proteins co-purifying with m7G sepharose in HCMV-infected 
cells. A stringent washing protocol was used to minimize false positive interactions. Elution 
of the bound proteins with free m7GTP added an additional degree of specificity to the 
purification protocol. As a further specificity control, we also identified host proteins that 
co-purify with sepharose beads without m7GTP. Very few proteins purified with the beads 
in the absence of m7GTP (Fig. S5). Proteins co-purifying with sepharose only beads are 
listed as likely contaminants in Table S1. Mass spectrometry identified many host proteins 
previously shown to associate with the mRNA cap including components of the eIF4F 
translation initiation complex, the cap binding complex (CBC), and gemin 5 [25-27] (Table 
S1). In addition peptides from two HCMV proteins were identified with high confidence, 
pTRS1 and pIRS1.
We confirmed the capture of both pTRS1 and pIRS1 on m7G sepharose from infected cell 
lysates by Western blot assay. pTRS1 and pIRS1 bound to the m7G resin throughout a time 
course of infection (Fig. 1A). pTRS1 and pIRS1 are identical in their first two thirds and 
appear to be functionally redundant [7, 9, 10], therefore we chose to focus our work on 
pTRS1. Free m7GTP inhibited the retention of pTRS1 on the m7G resin (Fig. 1B), 
demonstrating that pTRS1 recognized the m7G moiety rather than non-specifically binding 
to the resin. pTRS1 expressed outside the context of infection in HeLa cells also bound the 
m7G resin (Fig. 1C), demonstrating that additional viral proteins were not required for the 
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interaction. pTRS1 binding to m7G was resistant to micrococcal nuclease digestion (Fig. 
1D), indicating that the association was not brokered by an RNA intermediate. In fact 
nuclease treatment increased the pTRS1 binding to m7G resin. Partially purified, nuclease-
treated pTRS1 also co-purified with the m7G resin (Fig. 1E). The partially purified pTRS1 
preparation did not contain detectable levels of the host eIF4E cap binding protein or the 
eIF4G component of the eIF4F complex, suggesting that pTRS1 can directly associate with 
the mRNA cap. Consistent with previous reports that pTRS1 binds RNA [8, 28], pTRS1 was 
captured from transfected cell lysates with oligo-(d)T sepharose in an RNA-dependent 
manner (Fig. S1A), demonstrating the efficacy of the nuclease treatment. The addition of 
excess free m7GTP did not affect pTRS1 capture by the oligo-d(T) sepharose. This suggests 
that the association of pTRS1 with the mRNA cap and the remainder of the mRNA are 
separable interactions.
3.2 pTRS1 associates with mRNAs undergoing translation initiation
The association of pTRS1 with the mRNA cap suggested that pTRS1 might interact with the 
translation machinery during infection. We first determined if pTRS1 co-sedimented with 
ribosomal subunits in HCMV infected cells. Infected cells were treated with puromycin to 
dissociate ribosomes into 40 and 60S subunits, and cytoplasmic lysates were then subjected 
to centrifugation in linear sucrose gradients to separate the ribosomal subunits. pTRS1 co-
sedimented with the 40S ribosomal protein rpS6 and the 18S rRNA in a 10 to 20% sucrose 
gradient (Fig. S1B), arguing that pTRS1 associates with a very large structure, presumably 
the 40S ribosomal subunit, during infection.
To determine if pTRS1 associates with active initiation complexes during infection, we 
asked if pTRS1 co-localized with stress granules in HCMV infected cells. Stress granules 
contain stalled translation initiation complexes bound to polyadenylated mRNA [21]. 
Translation initiation factors, the 40S ribosomal subunit, and mRNA all localize to stress 
granules upon exposure to stress-inducing agents that limit mRNA translation. However, 
60S ribosomal subunits and active 80S ribosomes are excluded [29]. Stress granules were 
absent from cells infected with HCMV variants expressing a pTRS1-GFP or pIRS-GFP 
fusion protein as determined by the diffuse localization of the stress granule marker G3BP1 
(Fig. 2A,B) [30]. However, stress granules could be induced to form in infected cells by the 
addition of the stress-inducing agents, sodium arsenite and thapsigargin, as judged by the re-
localization of G3BP1 into discrete cytoplasmic puncta (Fig. 2 A,B). While pTRS1 displays 
a diffuse cytoplasmic localization in untreated cells, treatment with arsenite (Fig. 2A) or 
thapsigargin (Fig. 2C-E) induced pTRS1 re-localization into discrete puncta that co-stained 
for G3BP1. pIRS1 behaved similarly to pTRS1, displaying diffuse cytoplasmic localization 
in untreated cells, and co-localization with G3BP1 in discrete puncta in the presence of 
arsenite (Fig. 2B). The relocalization of GFP to stress granules was dependent on the fusion 
to pTRS1, as GFP did not co-localize with G3BP1 in cells infected with an HCMV strain 
expressing GFP that was not fused to a viral protein (Fig. 2C-E). We also found that host 
initiation factors including eIF4G, eIF4A, eIF4E, co-localized with pTRS1 in stress granules 
(Fig. 2C-E). Together these data suggest that pTRS1 associates with active translation 
initiation complexes in HCMV-infected cells.
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3.3 pTRS1 stimulates translation
We next tested if pTRS1 expression affected translation. Cells were transfected with 
increasing amounts of a vector expressing pTRS1 together with a fixed amount of the pGL3-
Control luciferase reporter construct, which expresses an mRNA encoding a 33 base pair 
5’UTR derived from the plasmid multi-cloning site upstream of the luciferase coding region. 
pTRS1 induced a dose-dependent increase in the amount of luciferase activity (Fig. 3A, top). 
At the maximal concentration of pTRS1 tested, we observed a 19-fold increase in luciferase 
activity. pTRS1 expression had a minimal effect on luciferase mRNA abundance (Fig. 3A). 
To measure the effect of the viral protein on the rate of global protein synthesis, cells were 
labeled briefly (30 min) with 35S-labeled amino acids at 24 h after transfection with the 
pTRS1 expression plasmid or a control plasmid expressing GFP. pTRS1 increased the rate 
of protein synthesis in transfected cells by approximately 50% as compared to control cells 
expressing the GFP protein (Fig. 3B and Fig. S4). Based on these data we conclude that 
pTRS1 expression is sufficient to stimulate the translation of a reporter gene and increase 
the rate of protein synthesis.
The presence of a non-canonical RNA binding domain (RBD) in pTRS1 [8] suggested that 
pTRS1 might preferentially affect the translation of mRNAs containing specific sequences. 
We therefore compared the effect of pTRS1 expression on the translation of reporter 
constructs in which the 5’UTR of host or viral mRNAs were cloned upstream of the 
luciferase coding region. pTRS1 stimulated translation of mRNAs containing either host or 
viral 5’UTRs (Fig 3C) to varying extents. pTRS1 increased expression of the host 5’UTR 
reporters 5-7 fold compared to cells expressing GFP. However, pTRS1 preferentially 
stimulated translation of the viral UL99 5’UTR (>15 fold), and to a lesser extent the UL44 
5’UTR (Fig. 3C). To rule out an effect of pTRS1 on transcription from the reporter 
constructs we measured the abundance of luciferase mRNA in control or pTRS1 expressing 
cells. pTRS1 did not alter the abundance of luciferase mRNA from any of the reporters, 
except the UL44 5’UTR containing reporter which was slightly increased (Fig. 3D). Thus, 
pTRS1 increased expression from two reporters containing HCMV 5’UTRs to a greater 
extent than the control or cellular 5’UTRs.
These data suggested that pTRS1 might preferentially stimulate translation of the pUL99 
5’UTR by recognizing specific sequences or structures in the RNA. We therefore 
determined if truncation of the UL99 5’UTR ameliorated the preferential effect of pTRS1 on 
UL99 5’UTR translation. pTRS1 stimulated expression of the full length UL99 5’UTR 
approximately 16 fold (Fig. 3E). pTRS1 also stimulated translation of a truncated UL99 
5’UTR lacking the first 200 nucleotides, but to a lesser extent which was comparable to that 
of the luciferase reporter lacking the viral 5’UTR (7 fold). Similar results were obtained over 
a range of pTRS1 concentrations (Fig. S2). pTRS1 expression did not increase the 
abundance of the luciferase mRNA transcribed from either reporter (Fig. 3E, S2). Together 
these data demonstrate that pTRS1 preferentially stimulates the translation of mRNAs 
containing specific sequences or features.
Previous work has shown that pTRS1 inhibits the double-stranded RNA-dependent protein 
kinase R (PKR) [7, 9]. Therefore an explanation for the preferential effect of pTRS1 on the 
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translation of the viral 5’UTR reporter could be that the full-length UL99 5’UTR activated 
PKR, while mRNAs transcribed from the pGL3-Control vector and the truncated viral 
5’UTR vector did not. We therefore measured the effect of each reporter on PKR T446 auto-
phosphorylation, a measure of its activation [31] in the presence or absence of pTRS1. 
Similar levels of phosphorylated PKR were observed following co-transfection of each 
reporter with a control plasmid expressing GFP, and in each case pTRS1 efficiently blocked 
PKR auto-phosphorylation (Fig. 3F).
We further explored this result by determining if the previously identified pTRS1 PKR 
binding domain was necessary for pTRS1 to stimulate translation and inhibit PKR 
activation. A pTRS1 mutant lacking its PKR binding domain (amino acids 679 to 795; 
TRS1-dPBD), [9] was less effective than wild-type pTRS1 at stimulating translation of the 
reporter mRNAs (Fig. 4A). A control experiment confirmed that RNA levels were not 
differentially affected (Fig. 4A). The pTRS1-dPBD mutant increased the overall rate of 
cellular protein synthesis similarly to wild-type pTRS1 (Fig. 4B), and bound the m7G 
mRNA cap as well as wild type pTRS1, if not better (Fig. S3). In addition PKR auto-
phosphorylation was inhibited equally as well by wild type pTRS1 or the pTR1-dPBD 
mutant (Fig. 4C). We conclude that in this setting the PKR binding domain is dispensable 
for inhibition of PKR auto-phosphorylation and increased levels of protein synthesis. 
However, the carboxyl-terminus of pTRS1 is necessary for the preferential stimulation of a 
reporter containing an HCMV 5’UTR.
We also assessed the ability of a pTRS1 mutant lacking its RNA binding domain (amino 
acids 84 to 246; TRS1-dRBD) [8] to stimulate mRNA translation. In initial experiments we 
found the expression of the TRS1-dRBD mutant to be consistently lower than that of wild-
type pTRS1. We therefore transfected higher amounts of TRS1-dRBD expression plasmid to 
achieve equivalent expression of the two proteins. Deletion of the pTRS1 RNA binding 
domain diminished the effect of pTRS1 on the translation of the full length and truncated 
UL99 5’UTRs, while RNA levels were not differentially affected (Fig. 4D). However the 
TRS1-dRBD mutant maintained the ability to stimulate translation of all reporters, albeit to 
a reduced level, and stimulated the overall level of protein synthesis to a comparable extent 
as wild type pTRS1 (Fig. 4E). TRS1-dRBD also retained the ability to co-purify with m7G 
sepharose (Fig. S3) and efficiently inhibit PKR auto-phosphorylation (Fig. 4F). We 
conclude that the pTRS1 RNA binding domain is necessary to preferentially stimulate the 
translation of mRNAs containing specific sequences or structures, but is dispensable for 
increased levels of protein synthesis and inhibition of PKR auto-phosphorylation.
We next determined if pTRS1 could stimulate translation in the absence of PKR. We first 
determined the effect of shRNA-mediated PKR depletion on pTRS1-stimulated reporter 
gene expression. In these experiments we used the UL99 5’UTR reporter, as the greatest of 
effect of pTRS1 was observed with this construct. pTRS1 expression resulted in a 
statistically significant increase in luciferase activity in PKR depleted cells (Fig. 5A, C). 
Interestingly wild type pTRS1 increased luciferase activity of all reporters tested to a similar 
extent in the absence of PKR (Fig. 5B), suggesting that a PKR-independent activity of 
pTRS1 results in a general increase in protein synthesis. In a second approach we measured 
the effect of pTRS1 on reporter gene expression and nascent protein synthesis in cells where 
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CRISPR/Cas9-mediated genome editing was used mutate the PKR gene, and thus abrogate 
its expression (Fig. 5F). pTRS1 increased luciferase activity and the overall level of protein 
synthesis in PKR null cells (Fig. 5D,E). We also compared the ability of pTRS1-dPBD and 
pTRS1-dRBD to stimulate translation in PKR null cells. Neither mutant stimulated 
translation to a significant extent (Fig. 5D). This data demonstrates that pTRS1 is capable of 
stimulating translation independent of its ability to inhibit PKR.
4 Discussion
In this study we found that HCMV pTRS1 stimulates mRNA translation through both PKR-
dependent and PKR-independent mechanisms. pTRS1 associated with the mRNA m7G cap 
(Fig. 1A-E and Table S1), co-sedimented with 40S ribosomal subunits (Fig. S1B) and co-
localized with stress granules in HCMV infected cells (Fig. 2A-E). Expression of pTRS1 
alone increased the overall level of protein synthesis (Fig. 3B, 4B, 4E and 5D) and 
stimulated the translation of a reporter gene expressing an mRNA with a short, non-
structured 5’UTR (Fig. 3A). pTRS1 stimulated the translation of reporters expressing 
mRNAs with different 5’UTRs to varying extents. In the comparison we studied, it 
increased expression from a reporter expressing an mRNA containing an HCMV 5’UTR to a 
two-fold (Fig. 3C, 3E, 4A and 4D) to 3-fold greater extent than the relatively short 5’UTR in 
a control reporter. Apparently, specific mRNA sequences or structures in viral transcripts 
influence responsiveness to pTRS1 expression. This preferential stimulatory effect requires 
the carboxyl terminal region of pTRS1 that contains its PKR binding domain (Fig. 4A) and a 
segment including the pTRS1 RNA binding domain (Fig. 4D). Inhibition of PKR activation 
contributed to the enhancement of translation by pTRS1, however pTRS1 also stimulated 
reporter gene expression and protein synthesis in cells lacking PKR (Fig. 5A, 5C, 5D). Thus 
pTRS1 enhances translation through both PKR-dependent and independent mechanisms.
pTRS1 was previously found to contain a non-canonical RNA binding domain capable of 
binding to uncapped, double-stranded RNA in vitro [8, 28]. Our results demonstrate that 
pTRS1 additionally interacts with the mRNA cap (Fig. 1A-E). Other viral proteins were not 
required for pTRS1 association with m7G sepharose as the interaction occurred in 
transfected cells. The interaction was resistant to micrococcal nuclease digestion (Fig. 1D), 
and therefore was not dependent on the presence of mRNA. Our finding that partially 
purified pTRS1 co-purified with m7G sepharose (Fig. 1E) suggests that pTRS1 may bind 
directly to the mRNA cap. This is consistent with our finding that the partially purified 
pTRS1 preparation did not contain detectable levels of the host eIF4E cap binding protein 
(Fig. 1E). However additional biochemical experiments are needed to fully explore this 
possibility. Our finding that pTRS1 co-purified with mRNA in the presence of excess 
m7GTP cap analog (Fig. S1A) suggests that pTRS1 likely associates with both the body of 
the mRNA and the mRNA cap, perhaps increasing the stability of pTRS1 interaction with its 
cognate mRNAs.
Our finding that pTRS1 prevented PKR auto-phosphorylation (Fig. 4B) clearly supports 
previous studies demonstrating that pTRS1 is a potent PKR inhibitor [7, 9]. Binding to 
double-stranded RNA induces PKR homodimer formation, subsequent auto-phosphorylation 
and activation [32, 33]. The ability of pTRS1 to inhibit PKR auto-phosphorylation therefore 
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suggests that pTRS1 inhibits PKR dimerization. However, the mechanism by which pTRS1 
prevents PKR auto-phosphorylation is unclear. pTRS1 mutants lacking either the RNA or 
PKR binding domain inhibited PKR auto-phosphorylation as efficiently as wild type pTRS1 
(Fig. 4C,F), suggesting that a physical interaction with RNA or PKR may not be necessary 
for pTRS1 to inhibit PKR activation. However, it is possible that pTRS1 binds PKR through 
a region other than the previously defined PKR binding domain and thus prevents its 
activation. Additional biochemical experiments will be needed to determine the precise 
mechanism by which pTRS1 inhibits PKR activation.
We also found that pTRS1 preferentially stimulated the translation of reporter mRNAs 
containing certain sequences or structures (Fig. 3E, 4A, 4D). The preferential effect of 
pTRS1 was dependent on the presence of PKR, as pTRS1 induced the different reporters to 
a similar extent in PKR-depleted cells (Fig. 5A,C). The preferential stimulation of the viral 
5’UTR required both the pTRS1 RNA and PKR binding domains (Fig. 4A,D). However, 
both the RNA and PKR binding domain mutants prevented PKR auto-phosphorylation, and 
presumably PKR activation (Fig. 4C,F). Thus the ability of pTRS1 to inhibit PKR auto-
phosphorylation does not correlate with its ability to preferentially stimulate translation of 
specific mRNAs. Perhaps in this system PKR is activation does not require auto-
phosphorylation. We find this possibility unlikely, as PKR mutants lacking the 
phosphorylation site measured in our assay have greatly reduced kinase activity [34]. We 
feel a more likely explanation is that an undetectable, but biologically significant, level of 
PKR phosphorylation occurs in the presence of the mutants, resulting in translation 
inhibition.
In either case, the fact that pTRS1 stimulates some reporters more than others in a PKR-
dependent manner suggest that PKR preferentially inhibits the translation of specific 
mRNAs. Binding to double stranded RNA structures, rather than specific mRNA sequences, 
activates PKR [32]. Once activated PKR globally suppresses mRNA translation by 
inactivating the eIF2α initiation factor. Perhaps recruitment of PKR to structures in mRNA 
5’UTRs results in the local activation of PKR, resulting in the preferential inhibition of 
PKR-bound RNAs. Such a scenario has previously been suggested for the preferential 
inhibition of specific cellular mRNAs by PKR [35, 36]. This possibility could explain how 
an undetectable level of PKR auto-phosphorylation might have a biologically significant 
effect. pTRS1 may bind similar RNA structures and prevent PKR recruitment, thus 
preventing local PKR activation. Additional studies to define the complement of RNAs 
bound by PKR and pTRS1 will be needed to clarify the mechanism of preferential effects of 
pTRS1 and PKR on mRNA translation.
We also found that pTRS1 stimulated mRNA translation in a PKR-independent manner. 
pTRS1 increased the expression of each of the tested reporters in PKR depleted or PKR 
deficient cells (Fig. 5A, B), and increased the overall level of protein synthesis in the 
absence of PKR (Fig. 5C). Thus pTRS1 stimulates translation in both a PKR-dependent and 
PKR-independent manner. How might pTRS1 stimulate translation independent of its 
antagonism of PKR? We propose that pTRS1 preferentially associates with viral mRNAs in 
a sequence-dependent manner and bridges their association with the translation machinery. 
Our data suggests that pTRS1 acts at the initiation step of mRNA translation, as pTRS1 
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associates with the m7G mRNA cap (Fig. 1A-E), co-sediments with 40S ribosomal subunits 
(Fig. S1B) and co-localizes with stress granules containing stalled translation initiation 
complexes in infected cells (Fig. 2A-E). Perhaps pTRS1 acts in concert with host translation 
initiation complexes to stimulate translation. Alternatively, pTRS1 could be part of an 
uncharacterized initiation complex. Based on the known role of pTRS1 in limiting PKR 
activity this may also allow for the continued translation of viral mRNAs in the presence of 
the host antiviral response. However, our data do not exclude the possibility that pTRS1 
may also regulate additional aspects of the antiviral response that might act to limit protein 
synthesis. For example pTRS1 could bind to dsRNA and limit OAS activation, and thus 
block RNaseL-dependent mRNA decay. Additional biochemical studies will be needed to 
define the molecular interactions underlying PKR-independent pTRS1 activity.
In sum, we have identified an HCMV protein, pTRS1, which is sufficient to increase the 
overall level of translation in transfected cells. pTRS1 stimulates the translation of 
individual mRNAs to different extents, raising the possibility that it favors translation of 
HCMV mRNAs while simultaneously blocking the host antiviral response. Based on these 
functions pTRS1 antagonists have strong potential as antiviral drugs. Such drugs could 
antagonize the ability of TRS1 to stimulate translation and relieve the viral block to PKR 
activity, thereby reducing viral protein synthesis while activating a key aspect of the host 
innate immune system.
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5’UTR 5’ untranslated region
PKR double stranded RNA-dependent protein kinase
eIF4F eukaryotic translation initiation factor 4F
S Svedberg units
eIF2 eukaryotic translation initiation factor 2
mTOR mechanistic target of rapamycin
4EBP1 eukaryotic translation initiation factor 4E binding protein 1
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eIF2α eukaryotic translation initiation factor 2 subunit α
GMP guanosine monophosphate
GTP guanosine triphosphate
PERK RNA-dependent protein kinase (PKR)-like ER kinase
HFFs human foreskin fibroblasts
BAC bacterial artificial chromosome
GFP green fluorescence protein




G3BP1 GTPase activating protein (SH3 domain) binding protein 1
eIF4E eukaryotic translation initiation factor 4E
eIF4G eukaryotic translation initiation factor 4G
eIF4A eukaryotic translation initiation factor 4A
PABP1 poly(A) binding protein, cytoplasmic 1
TRCN The RNAi Consortium
CRISPR clustered regularly interspaced short palindromic repeats
Cas9 CRISPR-associated protein Cas9
Tet tetracycline
PAM protospacer adjacent motif
AAVS1 adeno-associated virus integration site 1
CBC cap binding complex
RBD RNA binding domain
PBD PKR binding domain
MN Micrococcal Nuclease
WCL whole cell lysate
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HCMV pTRS1 associates with the m7G mRNA cap. (A) Cells were infected with 
BADinGFP (3 IU/cell) and proteins bound to m7G sepharose were analyzed by Western blot 
with the indicated antibodies. Samples were harvested at the indicated time after infection. 
(B) Lysates from cells infected with BADinTRS1GFP (72 hpi) were incubated with m7G 
sepharose in the presence of free m7GTP (+m7GTP). (C) HeLa cells were transfected with a 
expression vector encoding pTRS1 fused to the his epitope and analyzed as in B. (D) Same 
as in B, except that one sample was treated with micrococcal nuclease (+MN) prior to 
incubation with m7G sepharose. (E) Partially purified pTRS1 incubated with m7G sepharose 
and analyzed as in B. (Left) Coomassie stained acrylamide gel of Whole Cell Lysate (WCL) 
and partially purified pTRS1 (+Ni) (Right).(Middle) Western blot of WCL and partially 
purified pTRS1 (Right) Western blot of m7G-associated proteins following incubation with 
partially purified pTRS1.
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pTRS1 associates with active translation initiation complexes during HCMV infection. 
HFFs were infected with BADinTRS1GFP (A), BADinIRS1GFP (B) or BADinGFP (C-E) at 
a multiplicity of 0.5. (A & B) Cells were treated with sodium arsenite (+ARS, 0.5 mM) or 
vehicle for two hours at 72 hpi. Immunofluorescence confocal microscopy was used to 
visualize GFP (green), the stress granule marker protein G3BP1 (red) or nuclei (DAPI, 
blue). (C-E) Cells were infected with BADinGFP and treated with thapsigargin (+Tg, 2 
μg/ml) for one hour before fixation at 72 hpi. Confocal microscopy was used as above to 
visualize pTRS1 (red) together with eIF4E, eIF4G or eIF4A (purple). DAPI (blue) was used 
to visualize nuclei, and GFP (green) was used to identify infected cells.
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pTRS1 enhances translation of a reporter gene in a sequence dependent manner. (A) 
Increasing amounts of pTRS1 expression vector were co-transfected with a constant amount 
of pGL3-Control luciferase plasmid. The graph shows the fold change in luciferase activity 
(closed boxes) and luciferase RNA abundance (open boxes) compared control cells 
expressing GFP. (n=3) (B) pTRS1 or GFP expressing cells were incubated with radiolabeled 
amino acids for thirty minutes at twenty-four hours after transfection. The amount of 
radiolabel incorporated into acid-insoluble proteins was quantified using a scintillation 
counter. The rate of protein synthesis in control cells expressing GFP is set to 100. 
(CHX=cycloheximide; 100 μg/ml) (n=3) (C & D) A pTRS1 expression vector (0.2 μg) was 
co-transfected with reporters containing the 5’UTR from the indicated host (GAPDH, actin, 
tubulin) or viral (IE1, UL44, UL99) mRNAs upstream of the luciferase coding region. The 
graphs show the fold change in luciferase activity (C) or luciferase RNA abundance (D) in 
pTRS1-expressing cells relative to control cells expressing GFP. (n=3) (E) Cells were 
transfected with pGL3-Control (black bars), a reporter containing the 5’UTR of the HCMV 
UL99 mRNA (open bars), or a 5’ truncation of the UL99 5’UTR (grey bars) together with a 
GFP (GFP) pTRS1 expression vector (TRS1). The graphs show the fold change in luciferase 
activity (left side) and RNA abundance (right side) in TRS1 expressing cells relative to the 
GFP control (n=3). (F) Cells were transfected as in E. Extracts were analyzed by Western 
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blot using antibodies to PKR phosphorylated on T446 (PKR-P), total PKR, or the his 
epitope (TRS1). For all panels * = p-value < 0.05; ** = p value < 0.01; *** = p value < 
0.001.
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The pTRS1 PKR binding and RNA binding domains are dispensable to inhibit PKR auto-
phosphorylation, but necessary to preferentially stimulate translation. (A) Cells were 
transfected as in figure 3 with either pGL3-Control (black bars) or the UL99 5’UTR 
luciferase construct (open bars) together with either a control vector (GFP) or the indicated 
pTRS1 expression constructs. The graph shows the fold change in luciferase activity (left 
side) and RNA abundance (right side) in pTRS1 expressing cells relative to control cells 
expressing GFP (n=3). (B) The rate of nascent protein synthesis in cells expressing wild type 
pTRS1 or pTRS1 lacking the PKR binding domain was measured as in figure 3B (n=3). (C) 
Cells were transfected as in figure 3 with pGL3-Control vector or the UL99 5’UTR reporter 
together with a control vector (GFP) or the indicated pTRS1 constructs. PKR 
phosphorylation (PKR-P) was measured by Western blot. (D) Same as in A, except a pTRS1 
mutant lacking the RNA binding domain (333ng) and the truncated UL99 5’UTR pGL3-
Control construct was included (n=3). (E) The rate of nascent protein synthesis in cells 
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expressing wild type pTRS1 or pTRS1 lacking the RNA binding domain was measured as in 
figure 3B (n=3). (F) Cells were transfected with the UL99 5’UTR reporter together with a 
control vector (GFP) or the indicated pTRS1 construct. PKR auto-phosphorylation was 
measured by Western blot. For all panels * = p-value < 0.05; ** = p value < 0.01; *** = p 
value < 0.001.
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pTRS1 stimulates translation independent of PKR inhibition. (A) HeLa cells were 
transduced with scrambled (Scram) or PKR-specific shRNAs, and then transfected with full 
length UL99 5’UTR luciferase reporter together with a GFP or pTRS1 expression vector. 
The graph shows fold change in luciferase activity in pTRS1 expressing cells relative to 
GFP control cells (n=3). (B) Cells expressing PKR-specific shRNAs were transfected with 
the indicated reporters together with GFP or pTRS1 and assayed as in panel A (n=3) (C) 
Western blot showing reduced PKR expression in cells transduced with PKR-specific 
shRNAs. (D) The CRISPR/Cas9 system was used to generate HeLa cells lacking PKR or 
control cells lacking the AAVS gene. Cells were transfected with either GFP or the indicated 
pTRS1 constructs together with the full length UL99 5’UTR luciferase reporter. The graph 
shows fold change in luciferase activity in pTRS1 expressing cells relative to control (n=3). 
(E) The rate of nascent protein synthesis in PKR knockout cells expressing either GFP or 
pTRS1 was measured as in figure 3B (n=4) (F) Western blot showing PKR is not expressed 
in cells where the PKR gene was mutated using the CRISPR/Cas9 system. For all panels * = 
p-value < 0.05; ** = p value < 0.01; *** = p value < 0.001
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